Biomarkers for acute diagnosis and management of stroke in neurointensive care units

Biomarkers for acute diagnosis and management of stroke in neurointensive care units

The effectiveness of current management of critically ill stroke patients depends on rapid assessment of the type of stroke, ischemic or hemorrhagic, and on a patient′s general clinical status. Thrombolytic therapy with recombinant tissue plasminogen activator (r-tPA) is the only effective treatment...

Full description

Bibliographic Details
Main Authors: Olena Y Glushakova, Alexander V Glushakov, Emmy R Miller, Alex B Valadka, Ronald L Hayes
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Brain Circulation
Subjects:
Biomarker
blood
cerebrospinal fluid (CSF)
clinical trial
intracerebral hemorrhage (ICH)
ischemic stroke
serum
transient ischemic attacks (TIAs)
Online Access:http://www.braincirculation.org/article.asp?issn=2394-8108;year=2016;volume=2;issue=1;spage=28;epage=47;aulast=Glushakova

Internet

http://www.braincirculation.org/article.asp?issn=2394-8108;year=2016;volume=2;issue=1;spage=28;epage=47;aulast=Glushakova

Similar Items